Trial Profile
A Phase III Study of IPD-1151T in Patients With Interstitial Cystitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Feb 2022
Price :
$35
*
At a glance
- Drugs Suplatast tosilate (Primary)
- Indications Interstitial cystitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 20 May 2016 New trial record